Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Expression of the α1β1 integrin, VLA-1, marks a distinct subset of human CD4+ memory T cells
Itamar Goldstein, … , Hong Jiang, Leonard Chess
Itamar Goldstein, … , Hong Jiang, Leonard Chess
Published November 1, 2003
Citation Information: J Clin Invest. 2003;112(9):1444-1454. https://doi.org/10.1172/JCI19607.
View: Text | PDF
Article Aging

Expression of the α1β1 integrin, VLA-1, marks a distinct subset of human CD4+ memory T cells

  • Text
  • PDF
Abstract

The α1β1 integrin, very late antigen-1 (VLA-1), is a collagen receptor expressed in many CD4+ T cells localizing to inflamed tissues. Here we show that the expression of VLA-1 is a stable marker of a distinct subset of CD4+ memory T cells. Thus, in human peripheral blood lymphocytes (PBLs), approximately 1–4% of the CD4+ T cells express VLA-1, and following T cell receptor activation ex vivo, the percentage of VLA-1+ cells increases within the CD45RO+ population. Importantly, the activated VLA-1+ and VLA-1– cells can be isolated and maintained in culture as phenotypically stable subsets. Functionally, CD4+ memory T cells, operationally defined as the cells that divide rapidly following stimulation with a recall antigen, are highly enriched for VLA-1+ cells. Moreover, depletion of the small fraction of VLA-1+ cells present in CD4+ PBLs prior to stimulation significantly abrogated the proliferative response to recall antigens. Notably, the VLA-1+ cells in fresh CD4+ PBLs are composed of resting CD45RO+/RA–, CCR7–, CD62L+, CD25–, and VLA-4hi cells. Interestingly, this VLA-1+ subset is enriched for Th1-type cells, and Th1-polarizing conditions during T cell activation favor the emergence of VLA-1+ cells. Thus, VLA-1 expression is a stable marker of a unique subset of human memory CD4+ T cells that predominantly differentiates into Th1 cells.

Authors

Itamar Goldstein, Shomron Ben-Horin, Jianfeng Li, Ilan Bank, Hong Jiang, Leonard Chess

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
VLA-1 is expressed only in a subset of the activated CD45RO+ CD4+ T cell...
VLA-1 is expressed only in a subset of the activated CD45RO+ CD4+ T cells. (a) CD4+ T cells were isolated from PBLs as described in Methods. Subsequently, the cells were stimulated with irradiated APCs and TSST-1 (upper four panels) or anti-CD3 (bottom panel). The cultures were assayed at day 8 for the cell surface coexpression of CD4 and Vβ2, together with VLA-1, CD45RO, CD25, or VLA-2. The data shown are representative of at least ten independent experiments in different normal donors. (b) CD4+ PBLs were stimulated twice (every 10 days) with APCs and TSST-1. Subsequently, the cultures were purified into VLA-1– or VLA-1+ cell fractions. The cells were maintained in recombinant human IL-2–containing medium and stimulated every 10 days. The two cultures were analyzed for surface expression of VLA-1, both at day 1 and 8 weeks later. The data are representative of more than five independent experiments in different normal blood donors.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts